Citation Impact
Citing Papers
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
1995 Standout
Cell Death Mechanisms and the Immune System
1991
Inflammation and metabolic disorders
2006 StandoutNature
CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
1992
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator
1998
The history, properties, and biological effects of cachectin
1988 StandoutNobel
TNF? and the TNF receptor superfamily: Structure-function relationship(s)
2000
An Evolutionary and Functional Approach to the TNF Receptor/Ligand Family
1994 StandoutNobel
Fas and Fas Ligand: A Death Factor and Its Receptor
1994
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Protein folding in the cell
1992 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Adhesion receptors of the immune system
1990 StandoutNature
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
1993 StandoutNatureNobel
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
1993 Nature
The Fas Death Factor
1995 StandoutScience
Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase
1999
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
1999
Tumour necrosis factor and cancer
2009
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
1991
The TNF and TNF Receptor Superfamilies
2001 Standout
Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
1987
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme
2000 StandoutNobel
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
2002
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
2020
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.
1988
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.
1986 StandoutNobel
Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
1986 StandoutScienceNobel
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Tumor Necrosis Factor (TNF)
1985 StandoutScience
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
1998 StandoutScienceNobel
Constitutive synthesis of tumor necrosis factor in the thymus.
1992 StandoutNobel
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
1985 Nature
Human tumor necrosis factor. Production, purification, and characterization.
1985
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.
1992 StandoutNobel
Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions
1989 Science
Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.
1985
Structure and Function of Lipopolysaccharide Binding Protein
1990 StandoutScience
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001
Purification and characterization of a human tumor necrosis factor from the LuKII cell line.
1985
Contingent Genetic Regulatory Events in T Lymphocyte Activation
1989 Science
Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
1986 Nature
Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
1986
Cachectin alters anterior pituitary hormone release by a direct action in vitro.
1989 StandoutNobel
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
1985 StandoutScienceNobel
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
1985
Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.
1986
Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation and polyribonucleotide cleavage.
1989 StandoutNobel
Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
1987
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.
1985
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
1986
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
1990 StandoutScience
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
1985
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Folding and association of proteins
1987
Human Lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization
1985
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
1987
Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
1985
Seppuku and Autoimmunity
1992 StandoutScienceNobel
Viruses in Human Cancers
1991 StandoutScienceNobel
Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
1987
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
1985 StandoutScience
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
1986 Nature
Chimeric tumor necrosis factor receptors with constitutive signaling activity.
1995 StandoutNobel
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
1986 Nature
Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
1985
Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
1985
The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.
1992
Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression
1985
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
1999
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
1985 StandoutScienceNobel
Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
1991
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
1984 Nature
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
1985 StandoutNatureNobel
Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma Protein
1993 StandoutScienceNobel
Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro
1990
Unraveling Function in the TNF Ligand and Receptor Families
1994 StandoutScienceNobel
Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.
1985
Works of Peter Ng being referenced
Distinct Molecular Phenotypes in Murine Cardiac Muscle Development, Growth, and Hypertrophy
1998
Production of native, correctly folded bovine pancreatic trypsin inhibitor by Escherichia coli.
1986
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
1984 Nature